Injectable peptides These are administered deeper into the skin, allowing the ingredients to be delivered directly in the dermis (the deeper skin layer)
Use-level and cost considerations The four peptides have substantially different per-mg pricing and therefore different finished-product cost contributions at typical use levels: Matrixyl at 5% use level in a finished serum represents about $5-15 of peptide cost per 30 mL bottle (depending on volume procurement scale) Snap-8 at 7% use level: about $2-8 per 30 mL bottle GHK-Cu at 1% use level: about $0.50-2 per 30 mL bottle (lowest per-finished-unit because the use level is much lower) AHK-Cu at 0.5% use level: about $0.30-1.50 per 30 mL bottle For premium-positioned multi-active products, brands typically combine GHK-Cu + Matrixyl + Snap-8 in a single formulation
Traces of mercury in organs from primates with amalgam fillings
Where PDA upregulates VEGFR2 and promotes angiogenesis, TB-500 increases actin polymerization and enhances cellular migration
I'm finding now, as time goes on, that more and more women are being diagnosed with vitamin B12 deficiency in perimenopause and menopause, so just be aware of this one
And that indulgence, it goes into other things